These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8219442)

  • 21. Symptoms of withdrawal from tricyclic antidepressants.
    Agbayewa MO
    Can Med Assoc J; 1981 Sep; 125(5):420, 422. PubMed ID: 7284924
    [No Abstract]   [Full Text] [Related]  

  • 22. Antidepressant withdrawal syndromes: evidence for supersensitivity of cholinergic system as an etiologic factor.
    Dilsaver SC; Greden JF
    J Clin Psychopharmacol; 1983 Oct; 3(5):330. PubMed ID: 6630593
    [No Abstract]   [Full Text] [Related]  

  • 23. Heterocyclic antidepressant, monoamine oxidase inhibitor and neuroleptic withdrawal phenomena.
    Dilsaver SC
    Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(2):137-61. PubMed ID: 1968671
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sudden death related to selected tricyclic antidepressants in children: epidemiology, mechanisms and clinical implications.
    Varley CK
    Paediatr Drugs; 2001; 3(8):613-27. PubMed ID: 11577926
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Are antidepressants carcinogenic? A review of preclinical and clinical studies.
    Sternbach H
    J Clin Psychiatry; 2003 Oct; 64(10):1153-62. PubMed ID: 14658962
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: a prospective, controlled study.
    Nulman I; Rovet J; Stewart DE; Wolpin J; Pace-Asciak P; Shuhaiber S; Koren G
    Am J Psychiatry; 2002 Nov; 159(11):1889-95. PubMed ID: 12411224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment resistant hyperemesis gravidarum in a patient with type 1 diabetes mellitus: neonatal withdrawal symptoms after successful antiemetic therapy with mirtazapine.
    Schwarzer V; Heep A; Gembruch U; Rohde A
    Arch Gynecol Obstet; 2008 Jan; 277(1):67-9. PubMed ID: 17628816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Withdrawal reactions after clomipramine].
    Zemishlany Z; Aizenberg D; Hermesh H; Weizman A
    Harefuah; 1992 Oct; 123(7-8):252-5, 307. PubMed ID: 1459499
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antidepressant drugs: disturbing and potentially dangerous adverse effects.
    Settle EC
    J Clin Psychiatry; 1998; 59 Suppl 16():25-30; discussion 40-2. PubMed ID: 9796863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Behavioral and cognitive toxicity related to elevated plasma tricyclic antidepressant levels.
    Meador-Woodruff JH; Akil M; Wisner-Carlson R; Grunhaus L
    J Clin Psychopharmacol; 1988 Feb; 8(1):28-32. PubMed ID: 3350996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Fluoxetine and tricyclic antidepressants: clinical tolerance in short-term combined administration].
    Bonin B; Bertschy G; Baumann P; Francois T; Vandel P; Vandel S; Sechter D; Bizouard P
    Encephale; 1996; 22(3):221-7. PubMed ID: 8767051
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclic antidepressants and the risk of sudden cardiac death.
    Ray WA; Meredith S; Thapa PB; Hall K; Murray KT
    Clin Pharmacol Ther; 2004 Mar; 75(3):234-41. PubMed ID: 15001975
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tricyclic antidepressants in the treatment of depression. Do they still have a place?
    Judd F; Boyce P
    Aust Fam Physician; 1999 Aug; 28(8):809-13. PubMed ID: 10495531
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reactions to withdrawal of antidepressants, antiparkinsonian drugs, and lithium.
    Lawrence JM
    Psychosomatics; 1985 Nov; 26(11):869-74, 877. PubMed ID: 2867577
    [No Abstract]   [Full Text] [Related]  

  • 35. Psychotropic drug withdrawal and the dexamethasone suppression test.
    Kraus RP; Hux M; Grof P
    Am J Psychiatry; 1987 Jan; 144(1):82-5. PubMed ID: 3799844
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Central nervous system toxicity of tricyclic antidepressants: phenomenology, course, risk factors, and role of therapeutic drug monitoring.
    Preskorn SH; Jerkovich GS
    J Clin Psychopharmacol; 1990 Apr; 10(2):88-95. PubMed ID: 2140373
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tricyclic antidepressant use and risk of fractures: a meta-analysis of cohort and case-control studies.
    Wu Q; Qu W; Crowell MD; Hentz JG; Frey KA
    J Bone Miner Res; 2013 Apr; 28(4):753-63. PubMed ID: 23165455
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Treatment of depression using MAO-A inhibitors: an open study of a direct switch from moclobemide to tri-/tetracyclic antidepressants].
    Becker T; Struck M; Laux G
    Psychiatr Prax; 1989 Aug; 16 Suppl 1():44-7. PubMed ID: 2685856
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clonidine treatment of the opiate withdrawal syndrome. A review of clinical trials of a theory.
    Agren H
    Acta Psychiatr Scand Suppl; 1986; 327():91-113. PubMed ID: 3529831
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.